Pilot Study of LED for PIE and PIH
Launched by YANJUN DAN · Apr 4, 2024
Trial Information
Current as of June 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how special medical lights, called LEDs, can help prevent and treat two types of skin conditions known as Post-Inflammatory Erythema (PIE) and Post-Inflammatory Hyperpigmentation (PIH), which can cause dark spots on the skin. The study is open to healthy Asian adults aged 20 to 65 who have specific skin types. Participants will need to sign a consent form agreeing to take part in the study.
To join, you must not have any serious skin or health issues, be free from certain medications, and not be pregnant or breastfeeding. If you decide to participate, you can expect to receive treatment using these LEDs and help researchers learn more about their effectiveness. This study is currently recruiting participants, so if you meet the criteria, you could contribute to important research in skin health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy Asians;
- • 2. 20-65 years old;
- • 3. Fitzpatrick classification III-IV;
- • 4. Sign the informed consent form.
- Exclusion Criteria:
- • 1. Have abnormal skin manifestations, such as pigment diseases, photosensitivity diseases and other allergic diseases;
- • 2. Those with a history of abnormal systemic diseases, such as heart disease, liver disease, kidney disease, tumors, and mental illness;
- • 3. Women who are preparing for pregnancy, pregnant or breastfeeding;
- • 4. Have used photosensitizing drugs within two weeks before inclusion in this study;
- • 5. Topical or systemic drugs may be used during this study;
- • 6. bad habits, such as smoking, drinking, etc.;
- • 7. Volunteers who have recently participated in other clinical trials;
About Yanjun Dan
Yanjun Dan is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous clinical studies. With a focus on enhancing patient outcomes and safety, Yanjun Dan collaborates with healthcare professionals, researchers, and regulatory bodies to design and implement trials that adhere to the highest ethical and scientific standards. The organization emphasizes transparency, integrity, and collaboration, striving to contribute valuable insights to the scientific community and improve therapeutic options for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Trial Officials
Leihong Xiang, professor
Principal Investigator
Huashan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported